Potential $38.1M Payout to Life Tech CEO Greg Lucier Upon Completion of Acquisition by Thermo Fisher | GenomeWeb

NEW YORK (GenomeWeb News) – Life Technologies Chairman and CEO Greg Lucier could see a $38.1 million payday upon completion of Thermo Fisher Scientific's acquisition of the company, Life Tech said in its definitive proxy statement.

Similarly, other executives at the company could see large financial gains from the $13.6 billion deal announced in April.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.